Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
by
Alten, Rieke
, Philipp, Sandra
, van den Hoogen, Frank
, Pavelka, Karel
, Vulto, Arnold G.
, Puig, Luis
, Mangues, Maria Antonia
, Kristensen, Lars Erik
, Kvien, Tore K.
in
Antibodies
/ Basic Medicine
/ Biomedical and Life Sciences
/ Biomedicine
/ Biosimilar Pharmaceuticals - adverse effects
/ Biosimilar Pharmaceuticals - therapeutic use
/ Cancer Research
/ Current Opinion
/ Farmaceutiska vetenskaper
/ Humans
/ Medical and Health Sciences
/ Medicin och hälsovetenskap
/ Medicinska och farmaceutiska grundvetenskaper
/ Molecular Medicine
/ Nocebo Effect
/ Patient Medication Knowledge
/ Pharmaceutical Sciences
/ Pharmacotherapy
/ Physician-Patient Relations
/ Treatment Outcome
2018
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
by
Alten, Rieke
, Philipp, Sandra
, van den Hoogen, Frank
, Pavelka, Karel
, Vulto, Arnold G.
, Puig, Luis
, Mangues, Maria Antonia
, Kristensen, Lars Erik
, Kvien, Tore K.
in
Antibodies
/ Basic Medicine
/ Biomedical and Life Sciences
/ Biomedicine
/ Biosimilar Pharmaceuticals - adverse effects
/ Biosimilar Pharmaceuticals - therapeutic use
/ Cancer Research
/ Current Opinion
/ Farmaceutiska vetenskaper
/ Humans
/ Medical and Health Sciences
/ Medicin och hälsovetenskap
/ Medicinska och farmaceutiska grundvetenskaper
/ Molecular Medicine
/ Nocebo Effect
/ Patient Medication Knowledge
/ Pharmaceutical Sciences
/ Pharmacotherapy
/ Physician-Patient Relations
/ Treatment Outcome
2018
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
by
Alten, Rieke
, Philipp, Sandra
, van den Hoogen, Frank
, Pavelka, Karel
, Vulto, Arnold G.
, Puig, Luis
, Mangues, Maria Antonia
, Kristensen, Lars Erik
, Kvien, Tore K.
in
Antibodies
/ Basic Medicine
/ Biomedical and Life Sciences
/ Biomedicine
/ Biosimilar Pharmaceuticals - adverse effects
/ Biosimilar Pharmaceuticals - therapeutic use
/ Cancer Research
/ Current Opinion
/ Farmaceutiska vetenskaper
/ Humans
/ Medical and Health Sciences
/ Medicin och hälsovetenskap
/ Medicinska och farmaceutiska grundvetenskaper
/ Molecular Medicine
/ Nocebo Effect
/ Patient Medication Knowledge
/ Pharmaceutical Sciences
/ Pharmacotherapy
/ Physician-Patient Relations
/ Treatment Outcome
2018
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
Journal Article
Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
2018
Request Book From Autostore
and Choose the Collection Method
Overview
The nocebo effect is defined as the incitement or the worsening of symptoms induced by any negative attitude from non-pharmacological therapeutic intervention, sham, or active therapies. When a patient anticipates a negative effect associated with an intervention, medication or change in medication, they may then experience either an increase in this effect or experience it de novo. Although less is known about the nocebo effect compared with the placebo effect, widespread interest in the nocebo effect observed with statin therapy and a literature review highlighting the nocebo effect across at least ten different disease areas strongly suggests this is a common phenomenon. This effect has also recently been shown to play a role when introducing a medication or changing an established medication, for example, when switching patients from a reference biologic to a biosimilar. Given the important role biosimilars play in providing cost-effective alternatives to reference biologics, increasing physician treatment options and patient access to effective biologic treatment, it is important that we understand this phenomenon and aim to reduce this effect when possible. In this paper, we propose three key strategies to help mitigate the nocebo effect in clinical practice when switching patients from reference biologic to biosimilar: positive framing, increasing patient and healthcare professionals’ understanding of biosimilars and utilising a managed switching programme.
Publisher
Springer International Publishing
This website uses cookies to ensure you get the best experience on our website.